Health Technology
Peruvian companies developing health technologies
Developing medical devices, diagnostics, and healthcare software platforms defines the health technology sector. Regulatory approval timelines and shifting Medicare reimbursement models constantly inject liquidity into these equities. Currently, Merck & Co., Inc. dominates trading volume, whereas Zoetis, Inc. Class A logs the strongest 24-hour performance. The table below organizes vital technical and fundamental data points.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYUSEli Lilly and Company | 4.6 T PEN | 1,425 USD | +0.78% | 10 | 0.24 | 46.82 | 104.84 PEN | +50.54% | 0.47% | Strong buy |
 MRKUSMerck & Co., Inc. | 1.28 T PEN | 149.50 USD | +6.03% | 1.74 K | 8.69 | 152.68 | 3.37 PEN | −87.05% | 2.26% | Buy |
 PFEUSPfizer Inc. | 605.29 B PEN | 31.19 USD | +2.97% | 231 | 0.34 | 44.61 | 2.41 PEN | −59.24% | 5.59% | Neutral |
 MRNAUSModerna, Inc. | 355.78 B PEN | 246.00 USD | −3.15% | 300 | 1.05 | — | −27.26 PEN | −6.20% | 0.00% | Neutral |
 ZTSUSZoetis, Inc. Class A | 127.13 B PEN | 87.00 USD | +17.93% | 233 | — | 14.31 | 20.75 PEN | +4.59% | 2.38% | Neutral |